Becton Dickinson
Ken Gelhaus has extensive experience in leadership roles within the medical and healthcare sectors. Serving as VP/GM for Infusion Solutions and Clinical Solutions at BD from August 2018 to November 2021, Ken managed a global Clinical Solutions business with revenues of approximately $450 million. Subsequently, as Chief Commercial Officer (CCO) at Teknova from November 2021 to March 2024, Ken led commercial strategies. Prior experience at Danaher Corporation included roles as General Manager for Canada, overseeing $30 million in revenue, and Director positions focusing on R&D and business integration. Ken's academic credentials include an MBA from Northwestern University's Kellogg School of Management and a Bachelor of Science in Biochemistry from the University of Michigan.
This person is not in any teams
This person is not in any offices